Correlation of CD44v5 expression with invasiveness and prognosis in renal cell carcinoma

Journal of the Formosan Medical Association

Volumn 102, Issue 4, 2003, Pages 229-233

  Wu, Sheng Tang ^a   Sun, Guang Huan ^a   Hsieh, Dar Shih ^a   Chen, An ^a   Chen, Hong I ^a   Chang, Sun Yran ^a   Yu, Dah Shyong ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Antigens, CD44; Carcinoma, renal cell; Immunohistochemistry; Prognosis; Tumor markers, biological

Indexed keywords

HERMES ANTIGEN; ISOPROTEIN;

ADULT; ADVANCED CANCER; AGED; ANTIGEN DETECTION; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; CARCINOMA, RENAL CELL; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0042413656     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hayners BF, Liao HX, Patton KL: The transmembrane hyaluronate receptor (CD44): multiple functions, multiple isoforms. Cancer Cells 1991;3:347-50.
2. Screaton GR, Bell MV, Jackson DG, et al: Genomic structure of DNA encoding the lymphocyte homing receptor reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992;89: 12160-4.
3. Heider KH, Ratschek M, Zatloukal K, et al: Expression of CD44 isoforms in human renal cell carcinomas. Virchows Arch 1996; 428:267-73.
4. Sobin LH, Fleming ID: TNM classification of malignant tumors, fifth ed. (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997;80: 1803-4.
5. Kaufmann M, Heider KH, Sinn HP, et al: CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995;345:615-9.
6. Washington K, Gottfried MR, Telen MJ: Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. Hum Pathol 1994;25:1043-9.
7. Stauder R, Eistere W, Thaler J, et al: CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood 1995;85:2885-99.
8. Favort MC, Combaret V, Lasset C: CD44- a new prognostic marker for neuroblastoma. New Engl J Med 1993;329:1965.
9. Noordzij MA, van Steenbrugge GJ, Verkaik NS, et al: The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy. Clin Cancer Res 1997;3:805-15.
10. Hong RL, Pu YS, Hsieh TS, et al: Expression of E-cadherin and exon v6-containing isoforms of CD44 and their prognostic values in human transitional cell carcinoma. J Urol 1995;153:2025-8.
11. Ross JS, del Rosario AD, Bui HX, et al: Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma. Mod Pathol 1996;9:854-60.
12. Sugino T, Gorham H, Yoshida K, et al: Progressive loss of CD44 gene expression in invasive bladder cancer. Am J Pathol 1996; 149:873-82.
13. Masuda M, Takano Y, Iki M, et al: Expression and prognostic value of CD44 isoforms in transitional cell carcinoma of renal pelvis and ureter. J Urol 1999;161:805-9.
14. Speiser P, Wanner C, Tempfer C, et al: CD44 is independent prognostic factor in early-stage cervical cancer. Int J Cancer 1997; 74:185-8.
15. Wielenga VJ, Heider KH, Offerhaus GJA, et al: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993;53:4754-6.
16. Mulder JWR, Kruyt PM, Sewnath M, et al: Expression of exon v6 containing CD44 proteins in human colorectal cancer is associated with unfavorable prognosis in long term follow up. Lancet 1994;344:1470-2.
17. Terpe HJ, Störkel S, Zimmer U, et al: Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. Am J Pathol 1996;148:453-63.
18. Kan M, Aki M, Akiyama K, et al: High-level expression of the CD44 variant sharing exon v10 in renal cancer. Jpn J Cancer Res 1995;86:847-53.
19. de Alava E, Panizo A, Sola I, et al: CD44v6 expression is related to progression in renal epithelial tumors. Histopathology 1998; 33:39-45.
20. Hara I, Miyake H, Yamanaka K, et al: Expression of CD44 adhesion molecules in nonpapillary renal cell carcinoma and normal kidney. Urology 1999;54:562-6.
21. Paradis V, Ferligot S, Ghannam E, et al: CD44 is an independent prognostic factor in conventional renal cell carcinomas. J Urol 1999,161:1984-7.
22. Günthert U, Hofmann M, Rudy W, et al: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24.
23. Gao AC, Lou W, Dong JT, et al: CD44 is a metastatic suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res 1997;57:846-9.